A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
Status:
Completed
Trial end date:
2019-07-29
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, crossover trial to compare the efficacy and safety of 2 different
batches of subcutaneous dasiglucagon in patients with type 1 diabetes mellitus